These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19172649)

  • 1. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Neuroimage; 2009 Mar; 45(1 Suppl):S3-15. PubMed ID: 19041724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
    Chou YY; Leporé N; Avedissian C; Madsen SK; Parikshak N; Hua X; Shaw LM; Trojanowski JQ; Weiner MW; Toga AW; Thompson PM;
    Neuroimage; 2009 Jun; 46(2):394-410. PubMed ID: 19236926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.
    Apostolova LG; Morra JH; Green AE; Hwang KS; Avedissian C; Woo E; Cummings JL; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neuroimage; 2010 May; 51(1):488-99. PubMed ID: 20083211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated and manual hippocampal segmentation techniques: Comparison of results, reproducibility and clinical applicability.
    Hurtz S; Chow N; Watson AE; Somme JH; Goukasian N; Hwang KS; Morra J; Elashoff D; Gao S; Petersen RC; Aisen PS; Thompson PM; Apostolova LG
    Neuroimage Clin; 2019; 21():101574. PubMed ID: 30553759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
    Duara R; Loewenstein DA; Potter E; Appel J; Greig MT; Urs R; Shen Q; Raj A; Small B; Barker W; Schofield E; Wu Y; Potter H
    Neurology; 2008 Dec; 71(24):1986-92. PubMed ID: 19064880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI.
    Wolz R; Heckemann RA; Aljabar P; Hajnal JV; Hammers A; Lötjönen J; Rueckert D;
    Neuroimage; 2010 Aug; 52(1):109-18. PubMed ID: 20382238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects.
    Madsen SK; Ho AJ; Hua X; Saharan PS; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2010 Aug; 31(8):1312-25. PubMed ID: 20538376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
    Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
    Hua X; Lee S; Yanovsky I; Leow AD; Chou YY; Ho AJ; Gutman B; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Dec; 48(4):668-81. PubMed ID: 19615450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
    van de Pol LA; Korf ES; van der Flier WM; Brashear HR; Fox NC; Barkhof F; Scheltens P
    Arch Neurol; 2007 Jul; 64(7):1023-8. PubMed ID: 17620494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
    Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
    Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
    Leung KK; Barnes J; Ridgway GR; Bartlett JW; Clarkson MJ; Macdonald K; Schuff N; Fox NC; Ourselin S;
    Neuroimage; 2010 Jul; 51(4):1345-59. PubMed ID: 20230901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project.
    Yamaguchi S; Meguro K; Shimada M; Ishizaki J; Yamadori A; Sekita Y
    Neuroradiology; 2002 Jan; 44(1):43-8. PubMed ID: 11942499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly.
    Wolf H; Grunwald M; Kruggel F; Riedel-Heller SG; Angerhöfer S; Hojjatoleslami A; Hensel A; Arendt T; Gertz H
    Neurobiol Aging; 2001; 22(2):177-86. PubMed ID: 11182467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.